Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation. - Wikidata - awgldk - TriplyDB

Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation.

Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation.

http://www.wikidata.org/entity/Q35361243

about

Substance P-mediated expression of the pro-angiogenic factor CCN1 modulates the course of colitis Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural and immune pathogenicities Neuroimmunomodulation in the Gut: Focus on Inflammatory Bowel Disease The Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel Disease Biological and Pharmacological Aspects of the NK1-Receptor Upregulation of the transient receptor potential ankyrin 1 ion channel in the inflamed human and mouse colon and its protective roles Tachykinins potently stimulate human small bowel blood flow: a laser Doppler flowmetry study in humans.Treatment with neurokinin-1 receptor antagonist reduces severity of inflammatory bowel disease induced by Cryptosporidium parvum.Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer.Substance P modulates colitis-associated fibrosis Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation?Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia Neuropeptides, mesenteric fat, and intestinal inflammation.Acute restraint stress activates functional NK1 receptor in the colon of female rats: involvement of steroids.Changes in chemical coding of myenteric neurones in ulcerative colitis Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome.Substance P mediates pro-inflammatory cytokine release form mesenteric adipocytes in Inflammatory Bowel Disease patients Immunomodulatory properties of substance P: the gastrointestinal system as a model.Role of neuropeptides in inflammatory bowel disease.Substance P, obesity, and gut inflammation.Paradoxical regulation of ChAT and nNOS expression in animal models of Crohn's colitis and ulcerative colitis.Neuroinflammation in inflammatory bowel disease.Receptors and ligands role in colon physiology and pathology.The peritoneum--an important factor for pathogenesis and pain generation in endometriosis.Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel.Substance P and the regulation of inflammation in infections and inflammatory bowel disease.Identification and putative roles of distinct subtypes of intestinal dendritic cells in neuroimmune communication: what can be learned from other organ systems?Neurokinin-1 receptor expression and antagonism by the NK-1R antagonist maropitant in canine melanoma cell lines and primary tumour tissues.Substance P induces CCN1 expression via histone deacetylase activity in human colonic epithelial cells.Reciprocal Regulation of Substance P and IL-12/IL-23 and the Associated Cytokines, IFNγ/IL-17: A Perspective on the Relevance of This Interaction to Multiple Sclerosis.Neutral endopeptidase (EC 3.4.24.11) downregulates the onset of intestinal inflammation in the nematode infected mouse.Anti-emetic drug maropitant induces intestinal motility disorder but not anti-inflammatory action in mice.Identification of a novel substance P (SP)-neurokinin-1 receptor (NK-1R) microRNA-221-5p inflammatory network in human colonic epithelial cells.Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells.Increased expression of 5-HT3 and NK 1 receptors in 5-fluorouracil-induced mucositis in mouse jejunum.Intestinal motor disorders associated with cyclical bacterial overgrowth in a rat model of enteritis.Blockage of the neurokinin 1 receptor and capsaicin-induced ablation of the enteric afferent nerves protect SCID mice against T-cell-induced chronic colitis.Localisation and activation of the neurokinin 1 receptor in the enteric nervous system of the mouse distal colon.Impaired capsaicin and neurokinin-evoked colonic motility in inflammatory bowel disease.

P2860

Q24656280-E0572085-2636-4AE9-BF33-9438C10D887F Q24681823-D189270E-013A-46DA-B4B9-31EF81DCBD00 Q26741037-59DEF0E2-380D-4F45-81A0-E11E37DB305B Q26774660-B1928C5F-9E89-4D6E-A6DB-59A6786AC0C1 Q26784074-9A399218-54ED-4A44-9BD2-166CB5542D17 Q27345472-B5921363-F196-4D56-825C-5A1E0D7D0346 Q30873989-C60FE614-0765-41C1-9F21-6E9A71DC4C37 Q33942506-C2DB388C-B091-4103-B292-BB87526FEFA5 Q34039324-A32E6E48-5DD3-4680-96D8-21197069C97E Q34254416-96B0EF59-3C8F-4C9B-AD9B-12DC04ED12BD Q34597098-37A8D610-7892-4404-90F7-C39BF1D08BF9 Q34636181-98920059-B850-4441-B832-7E763B94F591 Q35069458-A269D8F4-727E-4B10-A49D-D3025FCFA97C Q35496179-B7BB0410-147C-481D-9354-8BC5A3014B6E Q35594450-A103ADDB-632A-46A0-8C6E-DFC580B316EF Q35595304-37CD5190-B83D-42D5-B48B-674ED052340E Q35994064-1E8EAEEA-9D12-4A37-8314-B32CD526D912 Q36238054-F564AD81-C964-4AB5-BCE5-13A5E777B52E Q36693928-52608045-1C19-4C39-841E-DB5D91BB5C74 Q36753635-048D3C92-3D88-4F3B-888C-240FE0A16FAB Q37356912-155849C1-8E6D-449A-B0C9-255C71FD3B4D Q37476404-F4062F18-A27C-4526-A60E-D4FF95798AA4 Q37771058-EC85A584-F2E1-40AD-B4A1-8FDF6D35CB58 Q38073798-256593BB-E1BB-4277-B675-5E2BD1BF0B39 Q38192902-764EF238-9681-4636-99EF-A09F3DA5999D Q38253468-76906A2B-8397-4AAD-88E0-4C03762B84F1 Q38271424-B064D098-C26F-4CDB-BC0F-9D2887703B02 Q38341386-EAF903FA-08A7-4ACE-A416-78B8FCD33EB6 Q38391996-7A92EA5C-88A2-4616-B1D5-E0550E87F80A Q38865042-ACDBE1D9-8A7C-452D-8218-C6CFDE4B7EAF Q38908679-A6CF67B8-5C21-4CB1-A741-698B5F0CA08C Q42133863-7C07C02E-2C13-45A2-8B57-1DB7204BCD19 Q42138581-C8F11C9B-3145-47A3-B76A-131EAB1A7826 Q42252901-C1A8F193-F9F7-464A-933C-51B51F893B58 Q42460283-5902C744-9560-4B8F-8885-230829DAA94F Q43471593-02308C72-AA95-4ED5-B277-CE02148CEF34 Q44764158-FEB0CB5A-9DF4-41FF-B890-A8F870F20C94 Q46072127-3DCEEACE-6F5A-4618-8CEE-30397F8DBEB0 Q46213275-69FCDAB4-1EDC-4496-8449-DC9E7D49567B Q46457443-C303A899-56FD-44C8-AFD3-B918857309A9

P2860

Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation.

http://www.wikidata.org/entity/Q35361243

description

2000 nî lūn-bûn

@nan

2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Neurokinin-1 receptor expressi ...... quantitation and localisation.

@ast

Neurokinin-1 receptor expressi ...... quantitation and localisation.

@en

type

label

Neurokinin-1 receptor expressi ...... quantitation and localisation.

@ast

Neurokinin-1 receptor expressi ...... quantitation and localisation.

@en

prefLabel

Neurokinin-1 receptor expressi ...... quantitation and localisation.

@ast

Neurokinin-1 receptor expressi ...... quantitation and localisation.

@en

P1433

Q35361243-FAA01449-EBF8-4F31-96F3-3E17187CC54D

P1476

Q35361243-FE7CEE27-C8EC-4B9D-B4A2-A8D7305F6BA9

P2093

Q35361243-419E78DE-B6EF-4B12-9CB0-5A9976B259CD

Q35361243-75AADBBD-482F-4817-B089-21FF40EEE86C

Q35361243-962D5389-AB7A-43F5-9892-83C588BE45E6

Q35361243-9C1C92AF-770B-40F2-BFDD-ABD9ED15B7A4

Q35361243-9D1A7C21-8AAE-43D7-87FF-B699F22D4901

Q35361243-B6D326EB-C9C4-4540-A535-D7334AE95FA6

Q35361243-D90168B8-8AE8-490A-A674-616F14A92CE5

Q35361243-FDD00AF7-7B51-426E-A0CE-6073EC14D1A1

P2860

Q35361243-131A85CF-F678-45FC-BA56-A54056C61F3E

Q35361243-1890666B-158D-4FAD-9218-D04A73D6DB24

Q35361243-26486B7D-FBDE-48F5-AA85-20C6FD468E48

Q35361243-27099E48-EAA0-430F-AA1D-853508FB1B87

Q35361243-2DD03224-C199-42C7-8F4F-92FA2330690A

Q35361243-365E3D7F-5F53-4032-87DC-417315507B70

Q35361243-38A12818-136D-436C-AAE5-4E4EDFAD0221

Q35361243-4F67130A-10DD-46C0-A6B8-0DFC17D94956

Q35361243-51F2E1FC-001B-4AEF-9632-2A96F90CC0D9

Q35361243-5447FC60-6594-41F6-B46F-0D9407EE47DA

P304

Q35361243-9A2D2D43-6BA1-403A-9EC8-13A9854433B2

P31

Q35361243-6E7D92EA-0B86-400C-AEC9-B024D053604D

P356

Q35361243-1F24ACDE-6D05-4BDE-BE4C-26B9C9B9C609

P407

Q35361243-AEB46C17-D306-4B85-BB08-3E0129E328A0

P433

Q35361243-BEBD65E2-4A82-4EC2-91B2-00419D7C7206

P478

Q35361243-BD7AD4A8-B453-46D7-8F92-89F2F5EB6645

P577

Q35361243-53D6BAE9-A135-4F84-8965-AE90E5BBA505

P5875

Q35361243-778BA523-8851-4C59-9E82-37DEBCA0A3EE

P698

Q35361243-BB43FEF2-78D6-409C-BCA8-952AF5941142

P921

Q35361243-5960AC53-FFED-4048-BBD7-AA5F35A7887A

P932

Q35361243-BA9A4F4F-4131-4D07-8F9A-B32A10D9982E

P356

P1433

P1476

Neurokinin-1 receptor expressi ...... quantitation and localisation.

@en

P2093

F Shanahan

http://www.w3.org/2001/XMLSchema#string

G C O'Sullivan

http://www.w3.org/2001/XMLSchema#string

H Wong

http://www.w3.org/2001/XMLSchema#string

J K Collins

http://www.w3.org/2001/XMLSchema#string

J O'Connell

http://www.w3.org/2001/XMLSchema#string

J Reeve

http://www.w3.org/2001/XMLSchema#string

P Anton

http://www.w3.org/2001/XMLSchema#string

T Goode

http://www.w3.org/2001/XMLSchema#string

P2860

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Agonist-induced internalization of the substance P (NK1) receptor expressed in epithelial cells

Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease.

Rapid endocytosis of a G protein-coupled receptor: substance P evoked internalization of its receptor in the rat striatum in vivo.

Substance P: a late-acting B lymphocyte differentiation cofactor.

Functional neurokinin 1 receptors for substance P are expressed by human vascular endothelium.

Progress in the development of potent bombesin receptor antagonists.

Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis

CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin.

Capsaicin-sensitive nerves in the gastrointestinal tract.

P304

387-396

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.47.3.387

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2000-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

245824846

http://www.w3.org/2001/XMLSchema#string

P698

10940277

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

1728039

http://www.w3.org/2001/XMLSchema#string